retatrutide fda approval timeline 2025 Status: July 2026 Update When Will Retatrutide Be FDA

What Patients Need to Know About the GLP-1 FDA Policy Changes Medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) belong to a class called glucagon-like peptide-1 (GLP-1) receptor agonists

References Athauda, D., et al

In 1846 he demonstrated that when there is an excess of glucose in the blood it gets captured by the liver and stored there as a white starchy substance he called 'glycogen', which the liver turned back into glucose when glucose levels in blood got too low (Karamanou Protogerous Tsoucalas

These medicines often called GLP-1 medications have become much more common over the past few years